Axogen, Inc. - 8-K Filing
Axogen agrees to acquire BioCircuit for $200M in cash; raises $4.91M via public offering (Items: 1.01 Entry into a Material Definitive Agreement, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $AXGN